β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome

(2019) Grace M McMacken et al.   HUMAN MOLECULAR GENETICS

Congenital Myasthenic Syndromes in 2018

(2018) Andrew G. Engel   Current Neurology and Neuroscience Reports

The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes

(2018) Grace McMacken et al.   HUMAN MOLECULAR GENETICS

Fundamental Molecules and Mechanisms for Forming and Maintaining Neuromuscular Synapses

(2018) Steven Burden et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Does albuterol have an effect on neuromuscular junction dysfunction in spinal muscular atrophy?

(2018) Maria Carmela Pera et al.   NEUROMUSCULAR DISORDERS

Overexpression of Sarcoendoplasmic Reticulum Calcium ATPase 2a Promotes Cardiac Sympathetic Neurotransmission via Abnormal Endoplasmic Reticulum and Mitochondria Ca 2+ RegulationNovelty and Significance

(2017) Julia Shanks et al.   HYPERTENSION

The Structure of Human Neuromuscular Junctions: Some Unanswered Molecular Questions

(2017) Clarke Slater   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ephedrine treatment for autoimmune myasthenia gravis

(2017) Alexander F. Lipka et al.   NEUROMUSCULAR DISORDERS

Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis

(2016) Fenfen Wu et al.   BRAIN

Congenital myasthenic syndromes

(2016) David Beeson   CURRENT OPINION IN NEUROLOGY

β 2 -Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)

(2016) Raymond T. Bartus et al.   NEUROBIOLOGY OF DISEASE

Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease

(2016) Muzamil Majid Khan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model—Recommendations for methods and experimental designs

(2015) Linda L. Kusner et al.   EXPERIMENTAL NEUROLOGY

Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models

(2015) Jaap J. Plomp et al.   EXPERIMENTAL NEUROLOGY

Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes

(2015) Pedro M. Rodríguez Cruz et al.   NEUROLOGY

How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia

(2014) J. R. Parr et al.   ARCHIVES OF DISEASE IN CHILDHOOD

The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle

(2014) Marta Gonzalez-Freire et al.   Frontiers in Aging Neuroscience

Is the decremental pattern in Lambert–Eaton syndrome different from that in myasthenia gravis?

(2013) D.B. Sanders et al.   CLINICAL NEUROPHYSIOLOGY

A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment

(2013) R.G. Webster et al.   EXPERIMENTAL NEUROLOGY

Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

(2013) Marco Morsch et al.   JOURNAL OF PHYSIOLOGY-LONDON

Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

(2012) Rinse Klooster et al.   BRAIN

Fiji: an open-source platform for biological-image analysis

(2012) Johannes Schindelin et al.   NATURE METHODS

Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers

(2011) Z. Chik et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia

(2011) Teerin Liewluck et al.   MUSCLE & NERVE

Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations

(2011) Menachem Sadeh et al.   MUSCLE & NERVE

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7

(2010) D. Lashley et al.   NEUROLOGY

Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7

(2009) A. Ben Ammar et al.   JOURNAL OF NEUROLOGY

Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations

(2009) U. Schara et al.   NEUROMUSCULAR DISORDERS

Terbutaline in myasthenia gravis: A pilot study

(2008) Betty Soliven et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease

(2008) Gordon S. Lynch et al.   PHYSIOLOGICAL REVIEWS